Drug costs Major PBMs are increasingly denying coverage of some drugs, negotiating discounts on others or requiring high co-pays for expensive treatments. (Photo: Shutterstock)

It's It's a tough time to be a middleman in the U.S. pharmacy business.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.